[Federal Register Volume 80, Number 3 (Tuesday, January 6, 2015)]
[Notices]
[Pages 513-514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-30879]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 514]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Therapeutic Agents that Target Cancer Stem Cells.
    Date: March 10-11, 2015.
    Time: 11:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W032, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Bethesda, MD 20892-9750, 240-276-6373, 
<a href="/cdn-cgi/l/email-protection#c5a7aca0a9a4b1ae85a8a4aca9ebabacadeba2aab3"><span class="__cf_email__" data-cfemail="c7a5aea2aba6b3ac87aaa6aeabe9a9aeafe9a0a8b1">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Research in Cancer Nanotechnology (IRCN).
    Date: March 19-20, 2015.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel and Conference Center 5701 
Marinelli Road Bethesda, MD 20852.
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Bethesda, MD 20892-9750, 240-276-6373, 
<a href="/cdn-cgi/l/email-protection#6d0f0408010c19062d000c040143030405430a021b"><span class="__cf_email__" data-cfemail="d1b3b8b4bdb0a5ba91bcb0b8bdffbfb8b9ffb6bea7">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Advance Culture Systems for Expansion of Cancer Stem Cells.
    Date: March 25-26, 2015.
    Time: 11:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E032, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Bethesda, MD 20892-9750, 240-276-6373, 
<a href="/cdn-cgi/l/email-protection#07656e626b66736c476a666e6b29696e6f29606871"><span class="__cf_email__" data-cfemail="610308040d00150a210c00080d4f0f08094f060e17">[email protected]</span></a>.

    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 30, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-30879 Filed 1-5-15; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>